FDA inspection
SPI Pharma, SAS: FDA inspection ending Apr 26, 2024
FDA inspection 1273714 · Voluntary Action Indicated (VAI) · Septemes Les Vallons
Key facts
| Inspection ID | 1273714 |
|---|---|
| Firm | SPI Pharma, SAS |
| FEI number | 3003755498 |
| Address | Septemes-Les Vallons, 845 Rue Du Vallon Du Maire |
| City | Septemes Les Vallons |
| Country | France |
| Fiscal year | 2024 |
| Inspection end date | Apr 26, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data